For: | Wang Z, Sheng YY, Dong QZ, Qin LX. Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis. World J Gastroenterol 2016; 22(10): 3038-3051 [PMID: 26973400 DOI: 10.3748/wjg.v22.i10.3038] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i10/3038.htm |
Number | Citing Articles |
1 |
Jingyi Dai, Jun Zhao, Yingrong Du, Lin Zhuang, Yanli Ma, Virasakdi Chongsuvivatwong. Clinico-Psychosocial Factors Predicting Hepatocellular Carcinoma Related Knowledge Among Patients with Chronic Liver Disease. Journal of Cancer Education 2020; 35(5): 937 doi: 10.1007/s13187-019-01545-y
|
2 |
Zhen Hu, Huaying Zhou. Clinical Characteristics of Non-B and Non-C Biopsy-Proven Primary Liver Cancers in an HBV- Endemic Area: A Retrospective Study. Journal of Hepatocellular Carcinoma 2024; : 767 doi: 10.2147/JHC.S455741
|
3 |
Seogsong Jeong, Ying Tong, Meng Sha, Jinyang Gu, Qiang Xia. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Oncotarget 2017; 8(10): 17292 doi: 10.18632/oncotarget.14079
|
4 |
Teresa Catalano, Federico Selvaggi, Diana Liberata Esposito, Roberto Cotellese, Gitana Maria Aceto. Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers. Microorganisms 2023; 11(7): 1632 doi: 10.3390/microorganisms11071632
|
5 |
Ajacio Bandeira de Mello Brandão, Santiago Rodriguez, Alfeu de Medeiros Fleck Jr, Claudio Augusto Marroni, Mário B Wagner, Alex Hörbe, Matheus V Fernandes, Carlos TS Cerski, Gabriela Perdomo Coral. Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant. World Journal of Clinical Oncology 2022; 13(8): 688-701 doi: 10.5306/wjco.v13.i8.688
|
6 |
Feng Yi Cheo, Kai Siang Chan, Vishal G Shelat. Outcomes of liver resection in hepatitis C virus-related intrahepatic cholangiocarcinoma: A systematic review and meta-analysis. World Journal of Virology 2024; 13(1): 88946 doi: 10.5501/wjv.v13.i1.88946
Abstract(287) |
Core Tip(273) |
Full Article(HTML)(1263)
|
Full Article with Cover (PDF)-3560K(56)
|
Full Article (Word)-244K(3)
|
Audio-1677K(3)
|
Peer-Review Report-216K(31)
|
Answering Reviewers-63K(36)
|
Supplementary Material-110K(34)
|
Full Article (PDF)-962K(54)
|
Full Article (XML)-202K(29)
|
Times Cited (0)
|
Total Visits (3135)
|
Open
|
7 |
Nikolaos Fragkou, Lazaros Sideras, Panteleimon Panas, Christos Emmanouilides, Emmanouil Sinakos. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?. World Journal of Gastroenterology 2021; 27(27): 4252-4275 doi: 10.3748/wjg.v27.i27.4252
|
8 |
Ramy El-Diwany, Timothy M. Pawlik, Aslam Ejaz. Intrahepatic Cholangiocarcinoma. Surgical Oncology Clinics of North America 2019; 28(4): 587 doi: 10.1016/j.soc.2019.06.002
|
9 |
Ruofan Sheng, Heqing Wang, Yunfei Zhang, Wei Sun, Kaipu Jin, Yongming Dai, Weiguo Zhang, Mengsu Zeng, Jianjun Zhou. MRI for Hepatitis B‐Associated Intrahepatic Cholangiocarcinoma: A Multicenter Comparative Study. Journal of Magnetic Resonance Imaging 2024; 59(3): 1093 doi: 10.1002/jmri.28855
|
10 |
Jianping Xiong, Yaqin Wang, Hanchun Huang, Jin Bian, Anqiang Wang, Junyu Long, Ying Zheng, Xinting Sang, Yiyao Xu, Xin Lu, Haitao Zhao. Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma. Oncotarget 2017; 8(35): 59648 doi: 10.18632/oncotarget.19570
|
11 |
Guoliang Chen, Song Li, Adong Xia, Yuelong Xing, Wenbo Liang. The Integrated Prediction of Clinical and Pathological Factors on the Prognosis of Intrahepatic Cholangiocarcinoma. The American Surgeon™ 2024; 90(6): 1481 doi: 10.1177/00031348241241730
|
12 |
Seogsong Jeong, Qingbao Cheng, Lifeng Huang, Jian Wang, Meng Sha, Ying Tong, Lei Xia, Longzhi Han, Zhifeng Xi, Jianjun Zhang, Xiaoni Kong, Jinyang Gu, Qiang Xia. Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3464-5
|
13 |
Seogsong Jeong, Lei Gao, Ying Tong, Lei Xia, Ning Xu, Meng Sha, Jianjun Zhang, Xiaoni Kong, Jinyang Gu, Qiang Xia. Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection. Canadian Journal of Gastroenterology and Hepatology 2017; 2017: 1 doi: 10.1155/2017/6543423
|
14 |
Yu Min, Xiaoyuan Wei, Xi Xia, Zhigong Wei, Ruidan Li, Jing Jin, Zheran Liu, Xiaolin Hu, Xingchen Peng. Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1141956
|
15 |
Kyungsik Ha, Masashi Fujita, Rosa Karlić, Sungmin Yang, Ruidong Xue, Chong Zhang, Fan Bai, Ning Zhang, Yujin Hoshida, Paz Polak, Hidewaki Nakagawa, Hong-Gee Kim, Hwajin Lee. Somatic mutation landscape reveals differential variability of cell-of-origin for primary liver cancer. Heliyon 2020; 6(2): e03350 doi: 10.1016/j.heliyon.2020.e03350
|
16 |
Jung Woong Seo, Byung Soo Kwan, Young Koog Cheon, Tae Yoon Lee, Chan Sup Shim, So Young Kwon, Won Hyeok Choe, Byung Chul Yoo, Jeong Min Yoon, Jung Hoon Lee. Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma. The Korean Journal of Internal Medicine 2020; 35(3): 566 doi: 10.3904/kjim.2018.062
|
17 |
Heejung Chae, Hyungwoo Cho, Changhoon Yoo, Kyu-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Jihoon Kang, Han Chu Lee, Young-Suk Lim, Kang Mo Kim, Ju Hyun Shim, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Shin Hwang, Gi-Won Song, Deok-Bog Moon, Young-Joo Lee, Jae Hoon Lee, Baek-Yeol Ryoo. Prognostic implications of hepatitis B virus infection in intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin. The International Journal of Biological Markers 2018; 33(4): 432 doi: 10.1177/1724600818777239
|
18 |
Núria Lluís, Domenech Asbun, Jaeyun Jane Wang, Hop S. Tran Cao, Ramon E. Jimenez, Adnan Alseidi, Horacio Asbun. Lymph Node Dissection in Intrahepatic Cholangiocarcinoma: a Critical and Updated Review of the Literature. Journal of Gastrointestinal Surgery 2023; 27(12): 3001 doi: 10.1007/s11605-023-05696-8
|
19 |
Harrys A. Torres, Terri Lynn Shigle, Nassim Hammoudi, James T. Link, Felipe Samaniego, Ahmed Kaseb, Vincent Mallet. The oncologic burden of hepatitis C virus infection: A clinical perspective. CA: A Cancer Journal for Clinicians 2017; 67(5): 411 doi: 10.3322/caac.21403
|
20 |
Xiaoli Huang, Dan Yu, Xintao Gu, Jiansun Li, Jiaqi Chen, Yuanqiang Zou, Jinyuan Liao. A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47108-6
|
21 |
C. Peraldo-Neia, P. Ostano, G. Cavalloni, Y. Pignochino, D. Sangiolo, L. De Cecco, E. Marchesi, D. Ribero, A. Scarpa, A. M. De Rose, A. Giuliani, F. Calise, C. Raggi, P. Invernizzi, M. Aglietta, G. Chiorino, F. Leone. Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma. BMC Genomics 2018; 19(1) doi: 10.1186/s12864-018-4829-0
|
22 |
Kutay Saglam, Yusuf Murat Bag, Zafer Bilen, Burak Isik, Cemalettin Aydin, Sezai Yilmaz. Results of Intrahepatic Cholangiocarcinoma Resections: a Single-Center Analysis. Journal of Gastrointestinal Cancer 2022; 53(4): 1034 doi: 10.1007/s12029-021-00781-0
|
23 |
Seogsong Jeong, Guijuan Luo, Zhi-Heng Wang, Meng Sha, Lei Chen, Qiang Xia. Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis. Hepatology International 2018; 12(4): 330 doi: 10.1007/s12072-018-9881-y
|
24 |
Massimiliano Cadamuro, Mario Strazzabosco. Hepatobiliary Cancers: Translational Advances and Molecular Medicine. Advances in Cancer Research 2022; 156: 39 doi: 10.1016/bs.acr.2022.02.001
|